J. Roberts and Marcia Fosberg Distinguished Professor of Pharmacotherapy Danial Baker published, “Drug evaluation – tenapanor (Ibsrela),” in Wolters Kluwer Health’s The Formulary Monograph Service (FMS) in January 2020. Wolters Kluwer Health is a drug and health information publisher, the FMS is a resource used in the formulary decision making process for hospitals and managed care systems on recently released and investigational drugs.
Danial Baker published, “Drug evaluation – trifarotene (Aklief),” in the FMS in January 2020.
Danial Baker and Drug Information Center Resident Brittany Craft published, “Drug evaluation – brolucizumab (Beovu),” in the FMS in January.
Pharmacotherapy Clinical Professor Terri Levien, Danial Baker, and one co-author published, “Drug evaluation – lasmiditan (Reyvow),” in the FMS in January 2020.
Terri Levien, Danial Baker, and one co-author published, “Drug evaluation – semaglutide, oral (Rybelsus),” in the FMS in January.
Danial Baker published, “Drug utilization evaluation – lasmiditan (Reyvow),” in the FMS in January 2020.
Allen I. White Distinguished Associate Professor of Pharmacotherapy Joshua Neumiller published the educational activity, “The role of GLP-1 RAs in the management of type 2 diabetes and cardiovascular risk: putting it all together,” for Postgraduate Healthcare Education, LLC. View the activity
Joshua Neumiller and one co-presenter presented “2020 ADA Standards of medical care in diabetes” for the Association of Diabetes Care & Education Specialists (ADCES) on January 30, 2020.
Joshua Neumiller presented “Update on the 2020 standards of medical care in diabetes” at the 67th Advanced Postgraduate Course of the American Diabetes Association (ADA) in San Francisco, California on January 31, 2020.
Joshua Neumiller and two co-presenters presented “Panel discussion on new medications: which to use, when and from whom?” at the 67th Advanced Postgraduate Course of the ADA on February 2, 2020.
Pharmacotherapy Clinical Assistant Professor Cheyenne Newsome was guest on an episode of the podcast Pharmacy Forward released February 20, 2020. Listen to the podcast
R. Keith Campbell Distinguished Professor in Diabetes Care and Pharmacotherapy Chair John White was quoted on intermittent fasting in both the Spokesman-Review and the WSU Insider. White spoke of the mounting evidence on the benefits of intermittent fasting, particularly for diabetes patients.
Pharmaceutical Sciences Research Technologist Kenneth Porter (Gaddameedhi lab) has been selected to receive a President’s Employee Excellence Award from Washington State University. Read more
Doctor of Philosophy (Ph.D) students
Panshak Dakup (pharmaceutical sciences, Gaddameedhi lab) with faculty co-authors Pharmaceutical Sciences Assistant Professor Zhaokang Cheng and Pharmaceutical Sciences Assistant Professor Shobhan Gaddameedhi, and Kenneth Porter and two other co-authors published, “The circadian clock protects against ionizing radiation-induced cardiotoxicity,” in the FASEB Journal, a peer-reviewed open-access resource, in February 2020. The findings of the article have been picked up by several news sites and blogs, including the Spokesman-Review.
Doctor of Pharmacy (Pharm.D.) students
Sally Hughes with faculty co-author Joshua Neumiller published, “Oral semaglutide,” in the American Diabetes Association Winter 2020 Clinical Diabetes Journal for Practical Information for Primary Care. Read more
Julianna Beauchene with faculty co-authors Terri Levien and Danial Baker published, “Drug evaluation – lasmiditan (Reyvow),” in the FMS in January 2020.
Kevin Kelley with faculty co-authors Terri Levien and Danial Baker published, “Drug evaluation – semaglutide, oral (Rybelsus),” in the FMS in January.